Related Experiment Videos
Atrial natriuretic peptide levels in the elderly: differentiating normal aging changes from disease
K M Davis1, L C Fish, K L Minaker
1Department of Geriatrics, North Mississippi Medical Center, USA.
Summary
Elevated atrial natriuretic peptide (ANP) levels in the elderly indicate cardiovascular disease, even in stable patients. A threshold of 21 pmol/L helps distinguish healthy elders from those with cardiac conditions.
Area of Science:
- Cardiology
- Gerontology
- Biomarkers
Background:
- Atrial natriuretic peptide (ANP) levels increase with age and cardiac dysfunction.
- Previous research has not clearly distinguished ANP elevation due to normal aging versus cardiac disease.
Purpose of the Study:
- To differentiate elevated ANP levels in healthy aging from those in cardiovascular disease.
- To establish ANP as a potential biomarker for cardiac comorbidity in the elderly.
Main Methods:
- Measured fasting supine ANP in healthy young, healthy old, and cardiovascularly diseased elderly individuals.
- Correlated ANP levels with clinical findings, lab results, functional status, and medications.
Main Results:
- ANP levels were significantly higher in healthy elderly compared to young individuals (p < .01).
- ANP levels were substantially higher in cardiovascularly diseased elderly compared to healthy elderly (p < .01).
- An ANP level of 21 pmol/L showed 83% sensitivity and 52% specificity for detecting cardiovascular disease in elders.
Conclusions:
- ANP levels exceeding 21 pmol/L are associated with cardiovascular comorbidity in stable elderly individuals.
- ANP elevation is a reliable indicator of underlying cardiac issues in the aging population.